Publication Name	World Journal of Clinical Cases
Manuscript ID	98553
Country	United Kingdom

Category	Biology
Manuscript Type	Letter to the Editor
Article Title	Early pirfenidone treatment enhances lung function in idiopathic pulmonary fibrosis patients
Manuscript Source	Invited Manuscript
All Author List	Jin-Wei Zhang
Funding Agency and Grant Number
Corresponding Author	Jin-Wei Zhang, BSc, MSc, PhD, Academic Editor, Professor, Senior Editor, Medical School, University of Exeter, Stocker Rd, Exeter EX4 4PS, United Kingdom. j.zhang5@exeter.ac.uk
Key Words	Idiopathic pulmonary fibrosis; Pirfenidone; Early intervention; Pulmonary function; Inflammatory markers
Core Tip	Early intervention with pirfenidone in idiopathic pulmonary fibrosis (IPF) patients significantly improves lung function, reduces inflammation, enhances physical endurance, and decreases adverse reactions. These findings underscore the potential of early pirfenidone treatment to alter the disease course and improve patient outcomes, emphasizing its importance in clinical management strategies for IPF.
Citation	<p>Zhang JW. Early pirfenidone treatment enhances lung function in idiopathic pulmonary fibrosis patients. <i>World J Clin Cases</i> 2024; 12(28): 6247-6249</p>

Received	2024-06-29 07:45
Peer-Review Started	2024-06-29 07:45
To Make the First Decision
Return for Revision	2024-07-17 21:08
Revised	2024-07-25 15:19
Second Decision	2024-07-30 02:43
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2024-07-30 07:57
Articles in Press	2024-07-30 07:57
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2024-07-31 15:53

ISSN	2307-8960 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com